Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07669753 · ClinicalTrials.gov registry record · NA
Advancing Cancer Control Engaged Research Through Transformative Solutions (ACCERT) Social Determinants of Health (SDoH) Navigation Program
A NA study, sponsored by Northwestern University.
- Recruiting
- Registry status
- NA
- Development phase
- 750
- Enrollment target
NCT07669753: Recruiting NA study, sponsored by Northwestern University.
NCT07669753 is a NA study that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 750 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (47% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07669753, a NA study, is actively recruiting participants, sponsored by Northwestern University.
- RECRUITING
- Registry status
- NA
- Development phase
- 750 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate patient navigation programs designed to reduce barriers to cancer screening and improve healthcare experiences for adults living in Chicago. Participants will be asked to complete two surveys: the first survey shortly after the participants join the study and a second survey after 1 year. Participants will be joining one of three patient navigation programs, assigned at random. The investigators expect the participants to be in this patient navigation program for 12 months, followed by a 1-month window to complete the final survey.
Primary Outcome
Patient Receipt of Clinical Cancer Preventive Services composite proportion of items completed/resolved in NCCN and USPSTF recommended cancer screenings, behavioral counseling, and immunizations.
Interventions
- OTHER Standard-PN
- OTHER 4R-PN
- OTHER AI-PN
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 750 participants |
| Start Date | 2026-06-01 |
| Est. Completion | 2029-08-31 |
| Phase | NA |
What NCT07669753 shows while recruiting
NCT07669753 is an interventional study that assigns participants to a tested intervention. The registered 750 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (47% lower).
The record links to 0 conditions, and to 3 interventions - of which Standard-PN is the first listed.
NCT07669753 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07669753 about?
NCT07669753 is a clinical study titled "Advancing Cancer Control Engaged Research Through Transformative Solutions (ACCERT) Social Determinants of Health (SDoH) Navigation Program". The purpose of this study is to evaluate patient navigation programs designed to reduce barriers to cancer screening and improve healthcare experiences for adults living in Chicago. Participants will be asked to complete two surveys: the first survey shortly after the participants join the study and...
What is the current status of trial NCT07669753?
This trial is currently recruiting. It is a NA study. The enrollment target is 750 participants. The study started on 2026-06-01. Estimated completion is 2029-08-31.
What interventions are being tested in trial NCT07669753?
The interventions under investigation include: Standard-PN (OTHER), 4R-PN (OTHER), AI-PN (OTHER).
Who is sponsoring clinical trial NCT07669753?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07669753's enrollment target sits among peer trials
750 145th of 2000 higher than 1,856 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02048332 · 750 participants · Phase 1
Donor-Derived Viral Specific T-cells (VSTs)
- NCT02087852 · 750 participants
Kidney Cancer DNA Registry
- NCT02532452 · 750 participants · Phase 2
Third Party Viral Specific T-cells (VSTs)
- NCT03126916 · 750 participants · Phase 3
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI